Clinical experience with the MammoSite® radiation therapy system for brachytherapy of breast cancer: Results from an international phase II trial

Radiotherapy and Oncology

Volumn 79, Issue 3, 2006, Pages 316-320

  Niehoff, Peter ^a   Polgár, Csaba ^b   Ostertag, Horst ^a   Major, Tibor ^b   Sulyok, Zoltán ^c   Kimmig, Bernhard ^a   Kovács, György ^a,d  

^a UNIVERSITY HOSPITAL SCHLESWIG HOLSTEIN   (Germany)

^b Department of Radiotherapy ^*

^c NATIONAL INSTITUTE OF ONCOLOGY   (Hungary)

^d UNIVERSITY HOSPITAL SCHLESWIG HOLSTEIN   (Germany)

Author keywords

Brachytherapy; Breast cancer; MammoSite ; Partial breast irradiation; Phase II trial

Indexed keywords

ABSCESS; ADULT; AGED; ARTICLE; BALLOON CATHETER; BRACHYTHERAPY; BREAST CANCER; CLINICAL ARTICLE; CLINICAL TRIAL; COMPUTER ASSISTED TOMOGRAPHY; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; ERYTHEMA; FOLLOW UP; HUMAN; HYPERPIGMENTATION; IMPLANTATION; MULTICENTER STUDY; PRIORITY JOURNAL; QUALITY OF LIFE; SURGICAL TECHNIQUE; TELANGIECTASIA; ULTRASOUND; X RAY;

AGED; AGED, 80 AND OVER; BRACHYTHERAPY; BREAST NEOPLASMS; CHEMOTHERAPY, ADJUVANT; DOSE FRACTIONATION; EQUIPMENT SAFETY; ERYTHEMA; FEASIBILITY STUDIES; FEMALE; HUMANS; HYPERPIGMENTATION; INTERNATIONAL COOPERATION; MIDDLE AGED; PROSPECTIVE STUDIES; SEROMA; TELANGIECTASIS; TOMOGRAPHY SCANNERS, X-RAY COMPUTED; TREATMENT OUTCOME;

EID: 33746374287     PISSN: 01678140     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.radonc.2006.05.010     Document Type: Article

References (25)

1. Arthur D.W., and Vicini F.A. MammoSite RTS: the reporting of initial experiences and how to interpret. Ann Surg Oncol 11 (2004) 723-724
2. Dickler A., Kirk M., Choo J., et al. Treatment volume and dose optimization of MammoSite breast brachytherapy applicator. Int J Radiat Oncol Biol Phys 59 (2004) 469-474
3. Dowlatshahi K., Snider H.C., Gittleman M.A., et al. Early experience with balloon brachytherapy for breast cancer. Arch Surg 139 (2004) 603-607
4. Edmundson G.K., Vicini F.A., Chen P.Y., Mitchell C., and Martinez A.A. Dosimetric characteristics of the MammoSite RTS, a new breast brachytherapy applicator. Int J Radiat Oncol Biol Phys 52 (2002) 1132-1139
5. Fentiman I.S., Poole C., Tong D., et al. Inadequacy of iridium implant as sole radiation treatment for operable breast cancer. Eur J Cancer Apr 32 (1996) 417-420
6. Fisher B., Bauer M., Margolese R., et al. Five year results of a randomized clinical trial comparing total mastectomy and segmental mastectomy with or without radiation in the treatment of breast cancer. New Engl J Med 312 665 (1985) 673
7. Hammer J., Mazeron J.J., and van Limbergen E. Breast boost-why, how, when...?. Strahlenther Onkol 175 (1999) 478-483
8. Harper J., Jenerette J.M., Vanek K.N., Aquero E.G., and Gillanders W.E. Acute complications of MammoSite Brachytherapy: a single institution's initial clinical experience. Int J Radiat Oncol Biol Phys. 61 (2005) 169-174
9. Keisch M., Vicini F., Kuske R.R., et al. Initial clinical experience with the MammoSite breast brachytherapy applicator in women with early-stage breast cancer treated with breast-conserving therapy. Int J Radiat Oncol Biol Phys 55 (2003) 289-293
10. Lawenda B.D., Taghian A.G., Kachnic L.A., et al. Dose-volume analysis of radiotherapy for T1N0 invasive breast cancer treated by local excision and partial breast irradiation by low-dose-rate interstitial implant. Int J Radiat Oncol Biol Phys 56 (2003) 671-680
11. Major T., Fodor J., Takacsi-Nagy Z., et al. Evaluation of HDR interstitial breast implants planned by conventional and optimized CT-based dosimetry systems with respect to dose homogeneity and conformality. Strahlenther Onkol 181 (2005) 89-96
12. King T.A., Bolton J.S., Kuske R.R., et al. Long-term results of wide-field brachytherapy as the sole method of radiation therapy after segmental mastectomy for Tis,1,2 breast cancer. Am J Surg 180 (2000) 299-304
13. Ott O.J., Pötter R., Hammer J., et al. Accelerated Partial Breast Irradiation with Iridium-192 Multicatheter PDR/HDR Brachytherapy Preliminary Results of the German-Austrian Multicenter Trial [Record Supplied By Publisher]. Strahlenther Onkol 180 (2004) 642-649
14. Polgar C., Fodor J., Major T., et al. Radiotherapy confined to the tumor bed following breast conserving surgery current status, controversies, and future projects. Strahlenther Onkol 178 (2002) 597-606
15. Polgar C., Major T., Somogyi A., et al. CT-image-based conformal brachytherapy of breast cancer. The significance of semi-3-D and 3-D treatment planning. Strahlenther Onkol 176 (2000) 118-124
16. Polgar C., Major T., Fodor J., et al. High-dose-rate brachytherapy alone versus whole breast radiotherapy with or without tumor bed boost after breast-conserving surgery: seven-year results of a comparative study. Int J Radiat Oncol Biol Phys 60 (2004) 1173-1181
17. Reitsamer R., Peintinger F., Kopp M., et al. Local recurrence rates in breast cancer patients treated with intraoperative electron-boost radiotherapy versus postoperative external-beam electron-boost irradiation. A sequential intervention study. Strahlenther Onkol J 180 (2004) 38-44
18. Richards G.M., Berson A.M., Rescigno J., et al. Acute toxicity of high-dose-rate intracavitary brachytherapy with the MammoSite applicator in patients with early-stage breast cancer. Ann Surg Oncol 11 (2004) 739-746
19. Sauer G., Strnad V., Kurzeder C., Kreienberg R., and Sauer R. Partial breast irradiation after breast-conserving surgery. Strahlenther Onkol 181 (2005) 1-8
20. Shah N.M., Tenenholz T., Arthur D., et al. MammoSite and interstitial brachytherapy for accelerated partial breast irradiation: factors that affect toxicity and cosmesis. Cancer 101 4 (2004) 727-734
21. Turreson I. Individual variation and dose dependency in the progression rate of skin teleangiectasia. Int J Radiat Oncol Biol Phys 19 (1990) 1569-1574
22. Van Limbergen E., Briot E., and Drijkoningen M. The source-skin distance measuring bridge: a method to avoid radiation teleangiectasia in the skin after interstitial therapy for breast cancer. Int J Radiat Oncol Biol Phys 18 (1990) 1239-1244
23. Vicini FA, Beitsch P, Quiet C, et al. First analysis of patient demographics and technical reproducibility by the American Society of Breast Surgeons (ASBS) MammoSite breast brachytherapy registry trial in 801 patients treated with accelerated partial breast irradiation (APBI). Proceedings of the San Antonio Breast Cancer Symposium, San Antonio, TX; December 10, 2004.
24. Wazer D.E., Lowther D., Boyle T., et al. Clinically evident fat necrosis in women treated with high-dose-rate brachytherapy alone for early-stage breast cancer. Int J Radiat Oncol Biol Phys 50 (2001) 107-111
25. WHO, Incidence, mortality and survival database; 2002. http://www5.who.int/cancer/main.cfm?p=0000000466